FDA Import Refusal SCS-2662323-2/41/1 — IBSA FARMACEUTICI ITALIA SRL
The FDA refused shipment SCS-2662323-2/41/1 from IBSA FARMACEUTICI ITALIA SRL (Italy) on Dec 19, 2018. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 19, 2018
- Country
- Italy
- Product Category
- Drugs and Biologics
- Product Code
- 62GAD18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 75